Quick Summary
- ARK divested more than 213,000 Nvidia shares valued at approximately $37 million throughout the week
- The firm liquidated over 90,000 Meta Platforms shares worth nearly $50 million
- Bitcoin ETF holdings were reduced alongside sales of cryptocurrency-related equity Bullish
- ARK acquired 41,830 CoreWeave shares representing roughly $3.1 million in investment
- Circle Internet Group emerged as the top purchase with 161,000+ shares totaling $16–17 million
Cathie Wood’s ARK Invest executed a substantial selling campaign throughout last week. The investment firm systematically exited positions in mega-cap technology companies, artificial intelligence-related holdings, cryptocurrency stocks, and consumer-facing internet businesses, while selectively establishing a handful of new positions.
Nvidia represented the largest divestment. ARK liquidated a total exceeding 213,000 shares distributed across its three exchange-traded funds — ARKK, ARKW, and ARKF — with an aggregate value surpassing $37 million. Advanced Micro Devices experienced a reduction of more than 57,000 shares, while Taiwan Semiconductor saw over 18,000 shares removed. Broadcom also faced a smaller position cut.
Teradyne represented another significant portfolio exit. ARK disposed of approximately 82,000 shares valued at roughly $24 million during the week, extending an ongoing trend of position reduction in this holding.
Among social media and digital platform investments, ARK divested over 90,000 shares of Meta Platforms, carrying a valuation approaching $50 million. The firm simultaneously reduced stakes in Alphabet, Netflix, Spotify, and Pinterest.
Cryptocurrency and High-Risk Positions Face Reductions
ARK decreased exposure to its proprietary ARK 21Shares Bitcoin ETF while maintaining its selling pattern in Bullish, a cryptocurrency-linked stock. Block experienced approximately 107,000 shares sold, representing over $6 million in value.
Speculative growth companies faced substantial reductions as well. Archer Aviation saw 899,000 shares eliminated from the portfolio. Roku endured a multi-session liquidation program totaling more than 234,000 shares. Recursion Pharmaceuticals witnessed 631,000 shares removed from ARK’s holdings.
Healthcare sector sales encompassed Illumina, Veracyte, Ionis Pharmaceuticals, and Natera. Defense contractors Kratos and BWX Technologies also experienced position reductions.
ARK’s Strategic Purchases
Acquisition activity remained concentrated but deliberate. Circle Internet Group dominated the buying activity. ARK accumulated more than 161,000 shares distributed among ARKF, ARKK, and ARKW, representing between $16 million and $17 million in capital deployment.
Tempus AI emerged as another significant acquisition, with approximately 146,000 shares purchased across ARKK and ARKG, valued at around $7 million. 10x Genomics attracted more than 121,000 shares worth nearly $2.5 million. Arcturus Therapeutics received an addition exceeding 53,000 shares.
Latest Daily Trading Activity
During Monday’s March 30 trading session, ARK acquired 41,830 CoreWeave shares through its ARKK ETF, representing approximately $3.1 million in investment.
That same session, ARK purchased 37,422 shares of Oklo alongside 20,674 shares of GeneDx Holdings. DoorDash received a modest addition of 2,527 shares.
Regarding selling activity that day, ARK eliminated 29,130 Teradyne shares valued at approximately $8.6 million, while disposing of 42,818 Veracyte shares worth about $1.3 million.
The complete roster of companies added to ARK’s portfolio throughout the entire week consisted exclusively of Circle Internet, Tempus AI, 10x Genomics, Arcturus Therapeutics, CoreWeave, Oklo, and GeneDx.





